Vernooij C B, Kruitwagen R F, Rodrigus P, Kock H C, Feyen H W
Bosch Medical Center, Department of Obstetrics and Gynecology, ME's-Hertogenbosch, The Netherlands.
Gynecol Oncol. 1997 Dec;67(3):325-7. doi: 10.1006/gyno.1997.4883.
The development of a hematometra after radiotherapy for cervical carcinoma is often related to recurrent disease. We present two cases in which a hematometra developed during the use of estrogen replacement therapy. This development was related to regained endometrial activity in combination with fibrosis and obliteration of the upper vagina and/or cervix. In one patient a dilatation and curettage could be performed; in the other a hysterectomy was necessary in order to exclude recurrent disease. These two cases show once more that endometrium can regain its proliferative activity after radiotherapy for cervical cancer. Estrogen replacement therapy in these patients should include the use of a progestagen agent in order to avoid continuous unopposed endometrial stimulation. In the absence of progesterone withdrawal bleeding the uterine cavity should be routinely examined for the development of a hematometra.
宫颈癌放疗后出现宫腔积血通常与疾病复发有关。我们报告两例在使用雌激素替代疗法期间发生宫腔积血的病例。这种情况的发生与子宫内膜活性恢复、上阴道和/或宫颈纤维化及闭锁有关。一例患者可行刮宫术;另一例则需要行子宫切除术以排除疾病复发。这两例再次表明,宫颈癌放疗后子宫内膜可恢复其增殖活性。这些患者的雌激素替代疗法应包括使用孕激素制剂,以避免子宫内膜持续受到无对抗的刺激。在无孕激素撤退性出血的情况下,应常规检查子宫腔是否有宫腔积血的发生。